X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.49	1.57	9.19	26.75	16.16	28.01
Short-Term Investments	0.59	3.09	38.77	-	-	-
Cash & Short-Term Investments	28.08	4.66	47.96	26.75	16.16	28.01
Cash Growth	604.21%	-90.28%	79.30%	65.57%	-42.33%	-35.48%
Accounts Receivable	74.54	0.25	27.65	0.59	3.71	5.07
Other Receivables	13.52	10.86	16.33	28.56	14.12	18.19
Receivables	88.05	11.11	43.98	29.15	17.83	23.26
Inventory	1.62	2.22	11.87	6.76	13.09	35.12
Prepaid Expenses	2.01	0.7	3.19	1.43	1.54	3.28
Other Current Assets	190.28	283.03	0.17	7.09	6.51	9.8
Total Current Assets	310.04	301.72	107.17	71.19	55.12	99.47
Property, Plant & Equipment	79.4	98.72	596.29	213.87	173.56	294.62
Long-Term Investments	-	-	27.25	-	-	-
Goodwill	-	123.39	335.35	246.18	267.44	516.1
Other Intangible Assets	2.24	70.86	319.23	146.54	150.05	364.85
Long-Term Deferred Tax Assets	-	-	0.13	-	-	-
Other Long-Term Assets	303.31	14.63	28.93	61.6	53.92	45.55
Total Assets	694.98	609.31	1,414	739.39	700.09	1,321

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	169.13	38.44	46.65	28.22	29.54	71.01
Accrued Expenses	-	45.45	39.3	38.33	25.24	17.5
Short-Term Debt	133.2	183.21	251.86	293.24	340.34	301.54
Current Portion of Long-Term Debt	2.75	2.93	3.05	3.05	3.21	3.14
Current Portion of Leases	4.62	14.64	22.16	26.64	27.23	36.39
Current Unearned Revenue	7.67	0.37	6.12	1.68	0.38	0.3
Other Current Liabilities	0.86	40.77	64.14	35.02	31.17	28.05
Total Current Liabilities	318.23	325.81	433.26	426.2	457.12	457.94
Long-Term Debt	3.24	3.71	5.93	8.29	10.68	13.2
Long-Term Leases	34.37	35.86	71.57	83.81	91.51	114.78
Pension & Post-Retirement Benefits	7.05	6.59	5.4	3.25	2.3	6.95
Long-Term Deferred Tax Liabilities	-	10.61	64.88	27.88	29.01	34.65
Other Long-Term Liabilities	2.07	3.53	5.88	7.15	6.94	19.66
Total Liabilities	364.97	386.11	586.93	556.58	597.55	647.19

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	85,057	7,352	1,944	1,031	813.91	813.91
Retained Earnings	-2,182	-1,845	-1,376	-1,116	-968.77	-397.91
Comprehensive Income & Other	-82,551	-5,290	-53.66	268.5	257.4	257.4
Total Common Equity	324.01	216.62	513.52	182.8	102.54	673.4
Minority Interest	6.01	6.58	313.91	0	0	0
Shareholders' Equity	330.01	223.2	827.43	182.81	102.54	673.41
Total Liabilities & Equity	694.98	609.31	1,414	739.39	700.09	1,321

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	178.18	240.36	354.56	415.04	472.98	469.05
Net Cash (Debt)	-150.11	-235.69	-306.6	-388.29	-456.82	-441.04
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.01	-0.59	-1.67	-3.10	-3.93	-3.79
Filing Date Shares Outstanding	12,151	1,050	277.66	147.23	116.27	116.27
Total Common Shares Outstanding	12,151	1,050	277.66	147.23	116.27	116.27
Working Capital	-8.2	-24.09	-326.09	-355.01	-402	-358.47
Book Value Per Share	0.03	0.21	1.85	1.24	0.88	5.79
Tangible Book Value	321.76	22.37	-141.06	-209.92	-314.95	-207.55
Tangible Book Value Per Share	0.03	0.02	-0.51	-1.43	-2.71	-1.79
Land	-	-	126	-	-	-
Buildings	-	63.21	109.74	-	-	-
Machinery	-	30.9	354.01	70.33	72.44	123.46
Construction In Progress	-	2.59	8.56	16.51	2.3	11.08

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error